Literature DB >> 10548598

Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease.

H Takahashi1, T Iwata, Y Kitagawa, R H Takahashi, Y Sato, H Wakabayashi, M Takashima, H Kido, K Nagashima, K Kenney, C J Gibbs, T Kurata.   

Abstract

We established four hybridoma cell lines producing monoclonal antibodies (MAbs) against 14-3-3 proteins. Immunoblot analysis revealed that epsilon and gamma isoforms were specifically increased in premortem cerebrospinal fluid samples from patients with sporadic Creutzfeldt-Jakob disease. Furthermore, dot immunoblot analysis showed that MAbs were more specific for native antigen than polyclonal antibodies were.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548598      PMCID: PMC95810          DOI: 10.1128/CDLI.6.6.983-985.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity.

Authors:  G Tzivion; Z Luo; J Avruch
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

2.  The 14-3-3 brain protein and transmissible spongiform encephalopathy.

Authors:  I Zerr; M Bodemer; T Weber
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

3.  A novel progressive spongiform encephalopathy in cattle.

Authors:  G A Wells; A C Scott; C T Johnson; R F Gunning; R D Hancock; M Jeffrey; M Dawson; R Bradley
Journal:  Vet Rec       Date:  1987-10-31       Impact factor: 2.695

4.  Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway.

Authors:  H Leffers; P Madsen; H H Rasmussen; B Honoré; A H Andersen; E Walbum; J Vandekerckhove; J E Celis
Journal:  J Mol Biol       Date:  1993-06-20       Impact factor: 5.469

Review 5.  14-3-3: modulators of signaling proteins?

Authors:  D Morrison
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

Review 7.  Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies.

Authors:  T Weber; M Otto; M Bodemer; I Zerr
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

8.  Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Authors:  M G Harrington; C R Merril; D M Asher; D C Gajdusek
Journal:  N Engl J Med       Date:  1986-07-31       Impact factor: 91.245

9.  Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.

Authors:  I Zerr; M Bodemer; M Otto; S Poser; O Windl; H A Kretzschmar; O Gefeller; T Weber
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

View more
  3 in total

Review 1.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

2.  Depletion of 14-3-3γ reduces the surface expression of Transient Receptor Potential Melastatin 4b (TRPM4b) channels and attenuates TRPM4b-mediated glutamate-induced neuronal cell death.

Authors:  Chang-Hoon Cho; Eunju Kim; Young-Sun Lee; Oleg Yarishkin; Jae Cheal Yoo; Jae-Yong Park; Seong-Geun Hong; Eun Mi Hwang
Journal:  Mol Brain       Date:  2014-07-22       Impact factor: 4.041

3.  Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum.

Authors:  Yuanyuan Lu
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.